Atlas Trials

Does BCG Vaccination Reduce Biomarkers of Alzheimer's Disease?

Clinical trial NCT06078891 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06078891
Sponsor
Tamir Ben-Hur
Status
ENROLLING_BY_INVITATION
Phase
Early Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease, Late Onset
Start date
2023-07-01
Primary completion
2025-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.